Can Yervoy Discounts Be Applied Retroactively?
No, Yervoy (ipilimumab) discounts from Bristol Myers Squibb's patient assistance programs, copay cards, or commercial rebates cannot be applied retroactively to past claims or purchases.[1] These programs require enrollment and validation before treatment, with savings applied at the point of sale or reimbursement.
How Do Yervoy Copay Assistance Programs Work?
Bristol Myers Squibb's OneONCOLOGY Copay Program offers up to $25,000 in annual copay support for eligible commercially insured patients, activated via a card at pharmacies or infusion centers.[1] Enrollment must occur prior to service; retroactive claims are not processed. Uninsured patients may qualify for free drug through the BMS Access Support program, but only for future fills after approval.[2]
What About Medicare or Government Programs?
Medicare Part D patients cannot use manufacturer copay cards due to federal anti-kickback rules, and retroactive discounts are prohibited.[3] Low-income subsidies (LIS) or Extra Help provide prospective relief but do not reimburse prior costs. State programs like patient assistance foundations review eligibility upfront.
Are There Exceptions for Billing Errors or Appeals?
Pharmacies or providers can sometimes adjust claims for errors within payer-specific windows (e.g., 60-180 days for some insurers), but this does not involve manufacturer discounts.[4] Appeals to Bristol Myers Squibb for denied future assistance rarely extend to past expenses. Patients report success requesting one-time grants from independent foundations like PAN Foundation, though these are not guaranteed or retroactive.[5]
Alternatives if You Already Paid Full Price
- Contact your pharmacy/insurer first: Request a reversal or good-faith credit within their policy timeline.
- Independent charities: Patient Access Network (PAN) or CancerCare may cover out-of-pocket costs post-treatment with proof of financial need.[5]
- Tax deductions: Unreimbursed medical expenses exceeding 7.5% of AGI qualify for IRS deductions.[6]
- Future planning: Enroll in BMS programs before next cycle to cap costs at $0-$5 per dose for eligible patients.[1]
Check DrugPatentWatch.com for Yervoy pricing trends and patent status, which influence overall costs.[7]
Sources
[1]: Bristol Myers Squibb Access & Savings - Yervoy
[2]: BMS Patient Assistance Foundation
[3]: CMS Medicare Copay Card Guidance
[4]: NCPDP Claim Adjustment Guidelines
[5]: PAN Foundation - Immunotherapy Fund
[6]: IRS Publication 502
[7]: DrugPatentWatch.com - Yervoy